Purchase Order N0018924PZ374
Award Date
7/1/24
Potential Completion Date
6/30/25
Potential Value
$248K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Awardee
Pathoseq Bio, LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
United States Minor Outlying Islands
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Pathoseq Bio, LLC, a small business limited liability company. The $155,106.15 firm-fixed-price contract is for genomic analysis services, with a period of performance through March 31, 2025. The contract was set aside for total small business participation. Pathoseq Bio specializes in advanced biological research, genomic analysis, and biothreat detection for federal...
This $77,750 firm-fixed-price purchase order was awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment and consumables. The contract provides Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, along with associated reagents and supplies, to support genomic research initiatives across the Department of Defense and other federal agencies. The award...
The U.S. Department of the Navy awarded a $247,371.53 firm-fixed-price purchase order contract to Praesensbio LLC, a for-profit limited liability company, for a "Sequence Based Detection Biothreat Agent" requirement. The contract has a period of performance through March 29, 2024 and was awarded on September 27, 2023 without a set-aside. The requirement was originally solicited as an 8(a) sole source opportunity. Based on the description, this contract appears to support the Department...
<p>The Department of the Navy Bureau of Medicine and Surgery awarded a $248,637.36 firm-fixed-price purchase order to Praesensbio LLC, a for-profit limited liability company, for sequence-based characterization of SARS. The contract has a performance period ending on September 26, 2023 and was awarded on September 26, 2022. The place of performance is Vietnam. No set-aside was used for this award.</p>
<p>This is a $747,499.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Bugseq Inc., a for-profit foreign-owned company, to provide development and clinical validation from metagenomics data using AI and machine learning techniques. The contract has an ultimate completion date of July 23, 2025 and was awarded on June 21, 2024. The contract does not have a set-aside designation.</p>
This is a firm-fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Pacific Biosciences of California, Inc. for $2,105,947.00. The contract has an ultimate completion date of September 30, 2020 and was awarded on September 28, 2015. It does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. Under this contract, they will provide sequencing...
This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a small business manufacturer of scientific equipment and reagents. The $227,225 contract provides NIAID's Vaccine Research Center with specialized single-molecule real-time (SMRT) sequencing kits and consumables, including SMRT cells, barcoded adapters, and binding reagents for their Sequel II DNA...
<p>This is a $63,112.50 firm fixed price purchase order contract awarded by the Office of Naval Research (ONR), a defense agency, to Quantum Si Incorporated, a self-certified small disadvantaged business. The contract is for the provision of sequencing reagents and chips to support 4 sequencing runs on a Platinum(R) system. The contract has an ultimate completion date of June 18, 2025 and was awarded on February 20, 2025. No set-aside was used for this contract.</p>
This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...